GNTA
Price
$3.49
Change
-$0.22 (-5.93%)
Updated
Aug 11, 04:35 PM (EDT)
Capitalization
67.87M
SONN
Price
$3.07
Change
+$0.19 (+6.60%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
20.17M
Interact to see
Advertisement

GNTA vs SONN

Header iconGNTA vs SONN Comparison
Open Charts GNTA vs SONNBanner chart's image
Genenta Science SpA
Price$3.49
Change-$0.22 (-5.93%)
Volume$900
Capitalization67.87M
Sonnet BioTherapeutics Holdings
Price$3.07
Change+$0.19 (+6.60%)
Volume$8.37K
Capitalization20.17M
GNTA vs SONN Comparison Chart in %
Loading...
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNTA vs. SONN commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNTA is a Hold and SONN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (GNTA: $3.71 vs. SONN: $2.88)
Brand notoriety: GNTA and SONN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNTA: 5% vs. SONN: 0%
Market capitalization -- GNTA: $67.87M vs. SONN: $20.17M
GNTA [@Biotechnology] is valued at $67.87M. SONN’s [@Biotechnology] market capitalization is $20.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNTA’s FA Score shows that 0 FA rating(s) are green whileSONN’s FA Score has 0 green FA rating(s).

  • GNTA’s FA Score: 0 green, 5 red.
  • SONN’s FA Score: 0 green, 5 red.
According to our system of comparison, both GNTA and SONN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNTA’s TA Score shows that 3 TA indicator(s) are bullish while SONN’s TA Score has 2 bullish TA indicator(s).

  • GNTA’s TA Score: 3 bullish, 5 bearish.
  • SONN’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, GNTA is a better buy in the short-term than SONN.

Price Growth

GNTA (@Biotechnology) experienced а -3.52% price change this week, while SONN (@Biotechnology) price change was +2.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNTA($67.9M) has a higher market cap than SONN($20.2M). SONN YTD gains are higher at: 97.260 vs. GNTA (-14.694).
GNTASONNGNTA / SONN
Capitalization67.9M20.2M336%
EBITDAN/A-13.69M-
Gain YTD-14.69497.260-15%
P/E RatioN/A0.29-
RevenueN/A1M-
Total CashN/A2.06M-
Total DebtN/A90.4K-
FUNDAMENTALS RATINGS
SONN: Fundamental Ratings
SONN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
23

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GNTASONN
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 28 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABVN0.22N/A
N/A
ABV Consulting Inc.
MNGPF2.19N/A
N/A
Man Group Plc
SIETY103.13N/A
N/A
D IETEREN GROUP NV
PLWN560.00N/A
N/A
Pinelawn Cemetery
OLYFF74.94N/A
N/A
Olympia Financial Group, Inc.

GNTA and

Correlation & Price change

A.I.dvisor tells us that GNTA and BEIGF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNTA and BEIGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNTA
1D Price
Change %
GNTA100%
-2.35%
BEIGF - GNTA
28%
Poorly correlated
N/A
PTHS - GNTA
25%
Poorly correlated
-4.47%
RLFTF - GNTA
24%
Poorly correlated
N/A
SONN - GNTA
22%
Poorly correlated
N/A
AUTL - GNTA
21%
Poorly correlated
-0.85%
More

SONN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SONN has been closely correlated with PTHS. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SONN jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
N/A
PTHS - SONN
70%
Closely correlated
-4.47%
SNBIF - SONN
28%
Poorly correlated
N/A
KOD - SONN
26%
Poorly correlated
-3.66%
RARE - SONN
25%
Poorly correlated
-1.04%
ELDN - SONN
25%
Poorly correlated
-1.09%
More